{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:09:02Z","timestamp":1793758142120,"version":"4.6.1"},"reference-count":172,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":3975,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1186\/s13613-015-0061-0","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T20:02:59Z","timestamp":1439236979000},"page":"21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":383,"title":["Mechanisms of antimicrobial resistance in Gram-negative bacilli"],"prefix":"10.1016","volume":"5","author":[{"given":"\u00c9tienne","family":"Rupp\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Louis","family":"Woerther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MCP.0b013e32835f27be","article-title":"Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and managment","volume":"19","author":"Barbier","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1186\/s13613-015-0061-0_bb0015","unstructured":"REA-Raisin Network (2012) Surveillance of nosocomial infections in critically ill adult patients, France, 2012. http:\/\/www.cclinparisnord.org. Accessed 26 Dec 2014"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajic.2011.05.020","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004\u20132009","volume":"40","author":"Rosenthal","year":"2012","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-015-0061-0_bb0030","unstructured":"European Center for Disease Control and Prevention (2013) European Antimicrobial Resistance Surveillance (EARS-Net) 2013. http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance. Accessed 29 Dec 2014"},{"issue":"Suppl 1","key":"10.1186\/s13613-015-0061-0_bb0035","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012","volume":"43","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","article-title":"High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia","volume":"184","author":"Chung","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011)","volume":"78","author":"Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1186\/s13613-015-0061-0_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1186\/s13613-015-0061-0_bb0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","article-title":"Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: an European perspective","volume":"68","author":"Aliberti","year":"2013","journal-title":"Thorax"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0065","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00134-012-2675-0","article-title":"Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit","volume":"38","author":"Razazi","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-015-0061-0_bb0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2010.07.002","volume":"36","author":"Hsueh","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0075","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1183\/09031936.00152514","article-title":"Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis","volume":"45","author":"Torres","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1186\/s13613-015-0061-0_bb0080","unstructured":"Center for Diseases Control and Prevention (2013) Threat report 2013. http:\/\/www.cdc.gov. Accessed 13 Mar 2015"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s13054-014-0480-6","article-title":"Antibiotic stewardship in the intensive care unit","volume":"18","author":"Luyt","year":"2014","journal-title":"Crit Care"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00134-015-3719-z","article-title":"Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0100","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc9062","article-title":"Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008","volume":"14","author":"Meyer","year":"2010","journal-title":"Crit Care"},{"issue":"1036","key":"10.1186\/s13613-015-0061-0_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of beta-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1469-0691.2004.00831.x","article-title":"Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?","volume":"10","author":"Livermore","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2012.06.004","article-title":"Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?","volume":"40","author":"Harris","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1469-0691.2002.00492.x","article-title":"Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation","volume":"8","author":"Goldstein","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0135","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.01823-12","article-title":"Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients","volume":"57","author":"Armand-Lefevre","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/cit395","article-title":"The use of cefepime for treating AmpC beta-lactamase-producing Enterobacteriaceae","volume":"57","author":"Tamma","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijantimicag.2012.10.022","article-title":"Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?","volume":"41","author":"Hilty","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0155","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/jac\/dks072","article-title":"Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units","volume":"67","author":"Thiebaut","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0160","doi-asserted-by":"crossref","first-page":"O879","DOI":"10.1111\/1469-0691.12663","article-title":"Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling","volume":"20","author":"Grohs","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0165","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/jac\/dkt212","article-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?","volume":"68","author":"Livermore","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0170","unstructured":"Beta-lactamase classification and amino-acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor-resistant enzymes. http:\/\/www.lahey.org\/studies. Accessed 23 Mar 2015"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0175","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/clinids\/10.4.850","article-title":"Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies","volume":"10","author":"Sirot","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0180","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342577","article-title":"Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection","volume":"35","author":"Quale","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0185","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1128\/JCM.39.6.2184-2190.2001","article-title":"Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital","volume":"39","author":"Mammeri","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.281.6.517","article-title":"Multiple antibiotic-resistant Klebsiellapneumoniae and Escherichia coli in nursing homes","volume":"281","author":"Wiener","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.40.2.509","article-title":"Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases","volume":"40","author":"Bauernfeind","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0200","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/AAC.32.8.1243","article-title":"Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins","volume":"32","author":"Matsumoto","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0167-4838(92)90121-S","article-title":"Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca","volume":"1122","author":"Barthelemy","year":"1992","journal-title":"Biochim Biophys Acta"},{"issue":"6\u20137","key":"10.1186\/s13613-015-0061-0_bb0210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijmm.2013.02.008","article-title":"CTX-M-type beta-lactamases: a successful story of antibiotic resistance","volume":"303","author":"D\u2019Andrea","year":"2013","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/CMR.00023-13","article-title":"Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M","volume":"26","author":"Woerther","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0220","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1086\/500936","article-title":"Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital","volume":"42","author":"Ben-Ami","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10096-011-1313-z","article-title":"Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards","volume":"31","author":"Rupp\u00e9","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/ciu957","article-title":"Antimicrobials increase travelers\u2019 risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"60","author":"Kantele","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-015-0061-0_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics","author":"Rupp\u00e9","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(13)70295-0","article-title":"Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial","volume":"14","author":"Derde","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0250","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jac\/dkl043","article-title":"Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England","volume":"57","author":"Livermore","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0255","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dku542","article-title":"Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15","volume":"70","author":"Soubirou","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0260","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.06233-11","article-title":"Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum beta-lactamase","volume":"56","author":"Lepeule","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0265","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC beta-lactamase-producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0270","unstructured":"European Committe on Antimicrobial Susceptibility Testing\u2014Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (2015) Guidelines 2015. http:\/\/www.eucast.org. Accessed 3 Mar 2015"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0275","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0280","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.00135-13","article-title":"Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-beta-lactamase-producing Escherichia coli","volume":"57","author":"Retamar","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"beta-Lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-015-0061-0_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0295","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates","volume":"16","author":"Lopez-Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0300","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","article-title":"Beta-lactam and beta-lactamase inhibitor combinations in the treatment of extended-spectrum beta-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?","volume":"15","author":"Harris","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1186\/s13613-015-0061-0_bb0305","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00134-013-3187-2","article-title":"Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial","volume":"40","author":"De Waele","year":"2014","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0315","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s00134-014-3403-8","article-title":"Risk factors for target non-attainment during empirical treatment with beta-lactam antibiotics in critically ill patients","volume":"40","author":"De Waele","year":"2014","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0320","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/cid\/cis916","article-title":"Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters","volume":"56","author":"Lee","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0325","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1469-0691.2005.01290.x","article-title":"High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients","volume":"12","author":"Goethaert","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0330","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dku468","article-title":"Epidemiology and risk factors for infections due to AmpC beta-lactamase-producing Escherichia coli","volume":"70","author":"Pascual","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0335","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0340","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","article-title":"An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","article-title":"Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study","volume":"11","author":"Walsh","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0350","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Canton","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CMR.00117-13","article-title":"OXA beta-lactamases","volume":"27","author":"Evans","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1186\/s13613-015-0061-0_bb0360","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1186\/s13613-015-0061-0_bb0365","doi-asserted-by":"crossref","unstructured":"Rupp\u00e9 E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH et al (2014) Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill 19(14)","DOI":"10.2807\/1560-7917.ES2014.19.14.20768"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0370","doi-asserted-by":"crossref","first-page":"O887","DOI":"10.1111\/1469-0691.12604","article-title":"Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country","volume":"20","author":"Birgand","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0375","doi-asserted-by":"crossref","first-page":"19457","DOI":"10.2807\/ese.15.01.19457-en","article-title":"Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain","volume":"15","author":"Barbier","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1186\/s13613-015-0061-0_bb0380","unstructured":"Institut National de Veille Sanitaire (2013) Episodes impliquant des ent\u00e9robact\u00e9ries productrices de carbap\u00e9n\u00e8mases en France: situation \u00e9pid\u00e9miologique du 1er avril 2013. http:\/\/www.invs.sante.fr. Accessed 29 Dec 2014"},{"key":"10.1186\/s13613-015-0061-0_bb0385","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1186\/s13613-015-0061-0_bb0390","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/652289","article-title":"Emergence of carbapenem-resistant Hafnia: the fall of the last soldier","volume":"50","author":"Skurnik","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1469-0691.2011.03515.x","article-title":"Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy","volume":"18","author":"Findlay","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1186\/s13613-015-0061-0_bb0400","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/AAC.02459-12","article-title":"Antibiotic trapping by plasmid-encoded CMY-2 beta-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli","volume":"57","author":"Goessens","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0405","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/AAC.01108-10","article-title":"Complete nucleotide sequence of plasmid pTN48, encoding the CTX-M-14 extended-spectrum beta-lactamase from an Escherichia coli O102-ST405 strain","volume":"55","author":"Billard-Pomares","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0410","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/AAC.00260-12","article-title":"Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto","volume":"56","author":"Lowe","year":"2012","journal-title":"Canada. Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0415","unstructured":"French National Observatory for Bacterial Resistance (ONERBA). 2009\u201310 Report. http:\/\/www.onerba.org. Accessed 26 Dec 2014"},{"issue":"8","key":"10.1186\/s13613-015-0061-0_bb0420","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/AAC.47.8.2565-2571.2003","article-title":"Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation","volume":"47","author":"Galimand","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0425","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/40.4.543","article-title":"Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae","volume":"40","author":"Deguchi","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1186\/s13613-015-0061-0_bb0430","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1186\/s13613-015-0061-0_bb0435","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1128\/AAC.01664-08","article-title":"Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection","volume":"53","author":"Allou","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0440","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0445","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.00143-07","article-title":"Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli","volume":"51","author":"P\u00e9richon","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2110-5820-3-18","article-title":"Outbreak of multidrug-resistant Klebsiella pneumoniae carrying qnrB1 and blaCTX-M15 in a French intensive care unit","volume":"3","author":"Filippa","year":"2013","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-015-0061-0_bb0455","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1186\/s13613-015-0061-0_bb0460","doi-asserted-by":"crossref","unstructured":"Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S et al (2012) Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill 17(7)","DOI":"10.2807\/ese.17.07.20088-en"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0465","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0470","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/AAC.43.4.882","article-title":"Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin","volume":"43","author":"Lister","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0475","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0480","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0485","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jac\/dkl504","article-title":"A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa","volume":"59","author":"Mesaros","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0490","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijantimicag.2014.07.022","article-title":"Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains","volume":"44","author":"Tsai","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-015-0061-0_bb0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2466-10-45","article-title":"Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review","volume":"10","author":"Zilberberg","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0500","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.03071-12","article-title":"Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital","volume":"51","author":"Koutsogiannou","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0505","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jac\/dku546","article-title":"Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study","volume":"70","author":"Willmann","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0510","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/AAC.03954-14","article-title":"The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility","volume":"59","author":"Kos","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0520","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0525","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0530","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1574-6968.2006.00195.x","article-title":"The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii","volume":"258","author":"Turton","year":"2006","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0535","first-page":"605","article-title":"When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever?","volume":"27","author":"Falagas","year":"2007","journal-title":"A decision analysis approach. Shock"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0540","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/civ048","article-title":"Colistin-resistant Acinetobacter baumannii: beyond carbapenemresistance","volume":"60","author":"Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0545","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/civ044","article-title":"Polymyxin-resistant Acinetobacter baumannii: urgent action needed","volume":"60","author":"Pogue","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0550","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0555","doi-asserted-by":"crossref","first-page":"e00013","DOI":"10.1128\/mBio.00021-13","article-title":"Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii","volume":"4","author":"Napier","year":"2013","journal-title":"MBio"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0560","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0565","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AAC.00766-07","article-title":"Colistin heteroresistance in acinetobacter and its association with previous colistin therapy","volume":"52","author":"Hawley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0570","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2009.05.019","article-title":"Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin","volume":"65","author":"Rodriguez","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0575","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"10.1186\/s13613-015-0061-0_bb0580","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1093\/cid\/ciu613","article-title":"A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections","volume":"59","author":"Ritchie","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0585","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc13858","article-title":"High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria","volume":"18","author":"De Pascale","year":"2014","journal-title":"Crit Care"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0590","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00365548.2013.871644","article-title":"Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii","volume":"46","author":"Soubirou","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1186\/s13613-015-0061-0_bb0595","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1186\/s13613-015-0061-0_bb0600","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/AAC.43.10.2366","article-title":"Characterization of the chromosomal aac(6\u2019)-Iz gene of Stenotrophomonas maltophilia","volume":"43","author":"Lambert","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0605","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/37.4.665","article-title":"Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia: alterations in protein and lipopolysaccharide with growth temperature","volume":"37","author":"Rahmati-Bahram","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0610","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0615","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.00496-09","article-title":"SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia","volume":"54","author":"Sanchez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.007","article-title":"High-level quinolone resistance is associated with the overexpression of SmeVWX in Stenotrophomonas maltophilia clinical isolates","author":"Garcia-Leon","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0625","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/AAC.48.1.168-171.2004","article-title":"Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis","volume":"48","author":"San Gabriel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0630","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0635","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1179\/1120009X12Z.00000000022","article-title":"Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections","volume":"24","author":"Tekce","year":"2012","journal-title":"J Chemother"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0640","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10096-014-2101-3","article-title":"Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia","volume":"33","author":"Betts","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0645","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/00365548.2012.732240","article-title":"Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates","volume":"45","author":"Church","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1186\/s13613-015-0061-0_bb0650","first-page":"CD003344","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","volume":"1","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-015-0061-0_bb0655","first-page":"CD003344","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","volume":"1","author":"Paul","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0660","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post-hoc analysis of a prospective cohort","volume":"57","author":"Pena","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0665","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0670","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0675","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/jac\/dku233","article-title":"Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort","volume":"69","author":"Lopez-Cortes","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0680","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0685","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/647284","article-title":"Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units","volume":"17","author":"Manian","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0690","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/AAC.38.6.1309","article-title":"Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients","volume":"38","author":"Cometta","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0695","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.01083-07","article-title":"Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use","volume":"52","author":"Choi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1186\/s13613-015-0061-0_bb0700","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10096-014-2124-9","article-title":"Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review","volume":"33","author":"Poulikakos","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0705","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/cid\/ciu847","article-title":"Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study","volume":"60","author":"Latibeaudiere","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0710","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1186\/s13613-015-0061-0_bb0715","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/AAC.00238-13","article-title":"Relative fecal abundance of extended-spectrum-beta-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women","volume":"57","author":"Rupp\u00e9","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"10.1186\/s13613-015-0061-0_bb0720","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","article-title":"Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients","volume":"343","author":"Donskey","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-015-0061-0_bb0725","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fmicb.2013.00129","article-title":"Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria","volume":"4","author":"Rupp\u00e9","year":"2013","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0730","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.CCM.0000152230.53473.A1","article-title":"First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit","volume":"33","author":"Nseir","year":"2005","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0735","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkt403","article-title":"Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime","volume":"69","author":"Grohs","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1186\/s13613-015-0061-0_bb0740","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1111\/j.1469-0691.2011.03649.x","article-title":"Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients","volume":"17","author":"Kontopidou","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1186\/s13613-015-0061-0_bb0745","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of beta-lactams","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1186\/s13613-015-0061-0_bb0750","article-title":"Perfomance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia","author":"Le Dorze","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0755","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1128\/JCM.03614-13","article-title":"Rapid detection of beta-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic Betalacta-test","volume":"52","author":"Morosini","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0760","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/JCM.00325-14","article-title":"Al Roomi E, Abdulaziz LR, Rotimi VO. Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia","volume":"52","author":"Jamal","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1186\/s13613-015-0061-0_bb0765","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1473-3099(11)70035-4","article-title":"Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study","volume":"11","author":"de Smet","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0770","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa0800394","article-title":"Decontamination of the digestive tract and oropharynx in ICU patients","volume":"360","author":"de Smet","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0775","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cid\/ciu740","article-title":"Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis","volume":"60","author":"Roquilly","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0780","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(12)70322-5","article-title":"Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis","volume":"13","author":"Daneman","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1186\/s13613-015-0061-0_bb0785","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2014.7247","article-title":"Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial","volume":"312","author":"Oostdijk","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0790","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.02634-12","article-title":"Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit","volume":"57","author":"Halaby","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0795","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijantimicag.2013.08.008","article-title":"Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience","volume":"42","author":"Lubbert","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0800","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.02234-12","article-title":"Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract","volume":"51","author":"Brink","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1186\/s13613-015-0061-0_bb0805","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/663206","article-title":"A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage","volume":"33","author":"Saidel-Odes","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0810","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ajic.2013.04.018","article-title":"Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial","volume":"41","author":"Oren","year":"2013","journal-title":"Am J Infect Control"},{"issue":"7","key":"10.1186\/s13613-015-0061-0_bb0815","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00134-014-3328-2","article-title":"SDD and colistin resistance: end of a dream?","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1186\/s13613-015-0061-0_bb0820","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2014.8427","article-title":"Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes","volume":"312","author":"Kollef","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1186\/s13613-015-0061-0_bb0825","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","article-title":"New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world","volume":"58","author":"Drawz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0830","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/beta-lactamase inhibitor combination","volume":"73","author":"Zhanel","year":"2013","journal-title":"Drugs"},{"key":"10.1186\/s13613-015-0061-0_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2014.12.033","article-title":"In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates","author":"Testa","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0840","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.04191-14","article-title":"In vitro susceptibility of characterized beta-lactamase-producing strains tested with avibactam combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1186\/s13613-015-0061-0_bb0845","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.02429-13","article-title":"Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-015-0061-0_bb0850","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ097","article-title":"Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI)","author":"Solomkin","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1186\/s13613-015-0061-0_bb0855","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cid\/cis857","article-title":"Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin\/tazobactam: a systematic review and meta-analysis","volume":"56","author":"Falagas","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1186\/s13613-015-0061-0_bb0860","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/cid\/cis286","article-title":"High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study","volume":"54","author":"Dalfino","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1186\/s13613-015-0061-0_bb0865","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-015-0061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13613-015-0061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025007344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025007344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-015-0061-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:15:54Z","timestamp":1776669354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025007344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["S2110582025007344"],"URL":"https:\/\/doi.org\/10.1186\/s13613-015-0061-0","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of antimicrobial resistance in Gram-negative bacilli","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-015-0061-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Rupp\u00e9 et al. 2015. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"21"}}